Genetic testing for rare diseases in India involves specialized techniques — whole exome sequencing (WES), whole genome sequencing (WGS), and targeted gene panels — that identify the specific DNA mutation causing a condition when standard tests have failed to provide a diagnosis.
What Is a Rare Genetic Disease?
A rare disease is defined as one that affects fewer than 1 in 2,000 people in a population. In India, approximately 70–80% of rare diseases have a genetic basis, and an estimated 70 million Indians live with a rare disease.
- 80% of rare diseases are genetic in origin
- Most present in childhood, though some appear in adults
- Average diagnostic odyssey: 5–7 years before a diagnosis
- Over 7,000 rare diseases have been identified globally
- Only 5% have an approved treatment — but a diagnosis still guides management and enables family planning
Common rare diseases in India include Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD), Pompe disease, Gaucher disease, various lysosomal storage disorders, rare chromosomal syndromes, and thousands of other single-gene disorders.
Types of Genetic Tests for Rare Diseases
1. Targeted Gene Panels
A targeted gene panel sequences a predefined set of genes associated with a specific disease category — an epilepsy panel, metabolic disorders panel, or skeletal dysplasia panel. Best when clinical features clearly point to a disease category but the specific gene is unknown.
2. Whole Exome Sequencing (WES)
WES sequences all protein-coding regions (exons) — roughly 20,000 genes. Since ~85% of known disease-causing mutations occur in exons, WES is the most widely used test for undiagnosed rare diseases. Recommended when targeted panels have not found a diagnosis.
3. Whole Genome Sequencing (WGS)
WGS sequences the entire genome, including non-coding regions and structural variants that WES may miss. Highest diagnostic yield but more expensive and complex to interpret. Used when WES has failed or when a specific non-coding variant is suspected.
4. Chromosomal Microarray (CMA)
Detects chromosomal copy number variants (CNVs) — large deletions or duplications. Often the first test ordered for children with developmental delays or multiple congenital anomalies, before WES is considered.
Cost Comparison: Genetic Tests for Rare Diseases in India
| Test | What It Detects | Cost (INR) | Turnaround | Best For |
|---|---|---|---|---|
| Targeted Gene Panel | SNVs/indels in specific gene set | ₹6,000 – ₹20,000 | 2–4 weeks | Specific disease category suspected |
| Chromosomal Microarray | Large chromosomal deletions/duplications | ₹8,000 – ₹18,000 | 2–3 weeks | Developmental delay, multiple anomalies |
| WES — Proband only | All coding gene variants | ₹15,000 – ₹35,000 | 4–8 weeks | Undiagnosed syndrome, panels negative |
| WES — Trio (patient + parents) | All coding variants + inheritance | ₹35,000 – ₹65,000 | 6–10 weeks | Best diagnostic yield (~40–50%) |
| WGS — Proband | Entire genome incl. non-coding | ₹25,000 – ₹50,000 | 6–12 weeks | WES negative, structural variants suspected |
| WGS — Trio | Entire genome + inheritance | ₹55,000 – ₹1,20,000 | 8–14 weeks | Maximum diagnostic resolution |
Important: Always consult a genetic counselor before ordering WES/WGS — an appropriate targeted panel may provide a faster, cheaper answer first. India's National Policy for Rare Diseases (2021) provides financial assistance of up to ₹50 lakhs for treatment; AIIMS Delhi and regional centres offer subsidized genetic testing.
Understanding Your WES Report
A definitive or near-definitive genetic cause found. Enables targeted management, family testing, and reproductive planning.
Found in 30–50% of reports. Not diagnostic but may be reclassified over time. Family testing can help clarify significance.
No disease-causing variant identified. Does not rule out a genetic cause — WES misses structural variants and intronic mutations.
Variants in genes unrelated to the reason for testing. You can choose whether to receive these before testing.
When to Consider Genetic Testing for Rare Disease
- Multiple congenital anomalies with no clear cause
- Unexplained intellectual disability or developmental delay
- A progressive neurological condition with unknown cause
- Metabolic crises or unusual lab results suggesting an inborn error of metabolism
- Features of a known syndrome but standard tests are negative
- Two or more prior genetic tests that were negative or inconclusive
- A family history of an undiagnosed condition affecting multiple relatives
Why You Need a Genetic Counselor for Rare Disease Testing
Navigating rare disease genetics is complex — not just technically, but emotionally. A genetic counselor reviews clinical history and prior tests to determine the most appropriate test, prevents unnecessary expense, explains what a positive/negative/VUS result would mean, interprets the report in clinical context, coordinates family testing, and provides guidance on management, clinical trials, and reproductive options.
"A genetic diagnosis — even for a condition with no cure — ends the diagnostic odyssey, connects families to support communities, enables accurate reproductive counseling, and may open access to clinical trials or emerging therapies."
After a Rare Disease Diagnosis
Connecting with disease-specific specialists (metabolic physician, neuromuscular specialist, cardiologist) for condition management.
Many emerging gene therapies and enzyme replacement therapies require a confirmed genetic diagnosis for trial eligibility.
Testing at-risk relatives (siblings, parents) to identify carriers or affected individuals who may benefit from early intervention.
For recessive conditions, future pregnancies can be monitored with prenatal testing or IVF+PGT-M.
Get Expert Guidance on Rare Disease Genetic Testing
Lakshita Thakore is a BGCI Certified Genetic Counselor with experience in rare disease diagnosis. She will review your case, recommend the right test, and help you understand your results.
Book a Consultation